Tenon Medical Inc (TNON) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

GuruFocus.com11-14

Release Date: November 13, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Tenon Medical Inc (NASDAQ:TNON) reported an 18% ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483384565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 15:16","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483384565","market":"us","top_or_hot":-1,"title":"Tenon Medical Inc (TNON) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...","media":"GuruFocus.com","content":"<div>\n<p>Release Date: November 13, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nTenon Medical Inc (NASDAQ:TNON) reported an 18% ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-inc-tnon-q3-071611805.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tenon Medical Inc (TNON) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenon Medical Inc (TNON) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tenon-medical-inc-tnon-q3-071611805.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Release Date: November 13, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nTenon Medical Inc (NASDAQ:TNON) reported an 18% ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-inc-tnon-q3-071611805.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNON","symbol_name":"Tenon Medical, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/tenon-medical-inc-tnon-q3-071611805.html","article_id":"2483384565","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483384565","pubTimestamp":1731568571,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Tenon Medical Inc  reported an 18% year-over-year increase in revenue for the first nine months of 2024, driven by a 5% rise in surgical procedures using the catamaran system.Gross margin improved significantly by 2,200 basis points to 54% for the first nine months of 2024 compared to the same period last year.The company strengthened its balance sheet with an investment from a healthcare-focused institutional investor, resulting in net proceeds of approximately $9.6 million.The company received three new patents related to its enhanced catamaran prosthesis, strengthening its competitive position in the industry.Revenue declined by 6% in the third quarter of 2024 compared to the same quarter in 2023, primarily due to unexpected reimbursement preauthorization headwinds.Operating expenses remain high, totaling $3.6 million for the third quarter of 2024, although this is a slight decrease f","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TNON":"Tenon Medical, Inc.","TNONW":"TENON MEDICAL INC"},"translate_title":"Tenon Medical Inc(TNON)2024年第三季度收益看涨期权亮点：收入增长和战略……","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNON":1,"TNONW":0.9},"content_text":"Release Date: November 13, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nTenon Medical Inc (NASDAQ:TNON) reported an 18% year-over-year increase in revenue for the first nine months of 2024, driven by a 5% rise in surgical procedures using the catamaran system.\nGross margin improved significantly by 2,200 basis points to 54% for the first nine months of 2024 compared to the same period last year.\nThe company strengthened its balance sheet with an investment from a healthcare-focused institutional investor, resulting in net proceeds of approximately $9.6 million.\nTenon Medical Inc (NASDAQ:TNON) has made considerable commercialization and technical advances, including the development of a second-generation, smaller version of the catamaran implant.\nThe company received three new patents related to its enhanced catamaran prosthesis, strengthening its competitive position in the industry.\n\n Negative Points \n\nRevenue declined by 6% in the third quarter of 2024 compared to the same quarter in 2023, primarily due to unexpected reimbursement preauthorization headwinds.\nGross profit margin decreased to 47% in the third quarter of 2024 from 57% in the same quarter of 2023.\nOperating expenses remain high, totaling $3.6 million for the third quarter of 2024, although this is a slight decrease from the previous year.\nThe company reported a net loss of $3.2 million for the third quarter of 2024, indicating ongoing financial challenges.\nTenon Medical Inc (NASDAQ:TNON) anticipates incurring additional losses in the future as it continues to invest in growth initiatives.\n\n Q & A Highlights \n\nWarning! GuruFocus has detected 3 Warning Signs with TNON.\n\nQ: What caused the unexpected reimbursement preauthorization headwinds, and have these issues been resolved? A: Steven Foster, CEO, explained that the reimbursement issues were due to regional coding confusion. They anticipate that upcoming coding clarity and their clinical data will help resolve these issues. The company views these challenges as transient and expects improvements into 2025.\nQ: How does the recently published clinical data impact the reimbursement and preauthorization challenges? A: Steven Foster clarified that while the clinical data reinforces the safety and effectiveness of their technology, it does not directly resolve coding issues. However, the combination of coding clarity and their data should help with coverage issues moving forward.\nQ: What feedback have you received from physicians regarding the Catamaran system, and have any changes been made based on this feedback? A: Steven Foster noted that feedback led to the development of the Catamaran SE, a smaller version of the system. This change caters to different physician preferences, allowing them to choose a system that fits their needs, whether they prefer a larger or smaller implant.\nQ: Are there plans to expand the sales force, and if so, when will this occur? A: Steven Foster confirmed that they are actively expanding their sales force. This expansion is geographically focused, targeting key opportunities to engage physicians and promote the Catamaran system.\nQ: How is Tenon Medical positioned financially to support its growth initiatives? A: Kevin Williamson, CFO, stated that the company has fortified its balance sheet with $9.2 million in cash and no outstanding debt as of September 30, 2024. This financial position supports their growth initiatives, including sales force expansion and the commercial launch of the Catamaran SE.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483384565"}